The precision of high-pressure homogenisation to achieve a 100 to 220 nm particle size window
Moosavi H, Maleknejad F, Hoseinipour Z, Hatami L, Zeynali M
Anyone evaluating AOD-9604 against MOTS-c is really comparing two distinct research categories: localized fat-tissue signaling versus cellular energy metabolism
Scale weight can rise for reasons that have nothing to do with added body fat: Increased training volume more muscle glycogen and water Appetite shifts (up or down) Hydration changes as routines change Lean mass increases if training quality improves In other words, BPC 157 weight gain may reflect changes in training and recovery rather than a direct "stores fat" effect
Pacemaker implantation may be needed for AVB
These risks are theoretical, not documented in human trials, but they are reasons community references include cycle off-periods